Geburtshilfe Frauenheilkd 1999; 59(9): 0
DOI: 10.1055/s-1999-5972
FALLBERICHT
Georg Thieme Verlag Stuttgart ·New York

Glyceryltrinitrat intravenös bei hypertensiven Erkrankungen in der Schwangerschaft - Ein altes Medikament mit neuer Indikation?

Intravenous Nitroglycerin as Second-line Treatment for Severe Hypertension in Pregnancy M. Hofmann1 ,  F. Bahlmann1 ,  E. Steiner1 ,  P. Brockerhoff1 ,  K. Pollow2
  • 1 Universitätsfrauenklinik
  • 2 Abteilung für Experimentelle Endokrinologie, Mainz
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 1999 (online)

Auch verfügbar auf
 

Zusammenfassung

Fragestellung: Ist bei schwerer hypertensiver Erkrankung in der Schwangerschaft (SIH) die intravenöse Glyceryltrinitratinfusion (GTN) in Ausnahmesituationen eine Behandlungsalternative? Patienten und Methode: Eine Patientin mit Pfropfgestose in der 27. SSW mit V. a. medikamenten-toxischem Leberschaden durch Dihydralazin und Methyldopa sowie eine Patientin in der 30. SSW mit SIH und vorzeitiger Wehentätigkeit ohne adäquates Ansprechen auf Dihydralazin wurden mit GTN perfusorgesteuert intravenös (0,5 - 4 mg/h) behandelt. Ergebnisse: In beiden Fällen konnte der Blutdruck unter GTN befriedigend gesenkt werden, wobei die uterusrelaxierende Wirkung von GTN in einem Fall zugleich ausgenutzt werden konnte. Schlußfolgerung: Nach unseren Ergebnissen steht mit GTN in begründeten Ausnahmefällen eine wirksame und sicher zu handhabende Behandlungsalternative in der Therapie der schweren SIH zur Verfügung, wenn Dihydralazin nicht oder nicht mehr anwendbar ist.

Abstract

Objective: Nitroglycerin was used successfully in the second-line treatment of severe hypertension in two pregnant patients. Case report: One patient with preexisting hypertension developed severe hypertension at 27 weeks' gestation. Treatment with dihydralazine and methyldopa caused toxic liver damage. Another patient had severe hypertension unresponsive to dihydralazine an also had uterine contractions. Both patients received intravenous nitroglycerin at a rate of 0.5 - 4.0 mg/h over a period of 3 days. Maternal mean blood pressure returned to an almost normal level and uterine contractions ceased. There were no negative effects on mother or fetus. Conclusion: Nitroglycerin may be considered for short-term second-line treatment of severe hypertension in pregnancy.

Literatur

  • 01 Abrams,  J.. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia.  Amer. J. Cardiol.. 70 1992;  30-42 B.
    Google Scholar
  • 02 Begum,  S., , Yamasaki,  M. , Mochizuki M. . Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia.  J. Obstet. Gynaecol. Res.. 22 1996;  551-559.
    Google Scholar
  • 03 Bernheim,  J.. Hypertension in pregnancy (clinical conference).  Nephron.. 76 1997;  254-263.
    Google Scholar
  • 04 Black,  R.  S., , Flint,  S. , Lees,  C. , Campbell S. . Preterm labour and delivery.  Europ. J. Pediatr.. 155 (Suppl. 2) 1996;  2-7.
    Google Scholar
  • 05 Blea,  C., , Barnard,  J.  M. , Magness,  R.  R. , Phernetton,  T.  M. , Hendricks S.  K. . Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe.  Amer. J. Obstet. Gynecol.. 176 1997;  922-930.
    Google Scholar
  • 06 Bootstaylor,  B.  S., , Roman,  C. , Julian,  T.  P. , Heymann M.  A. . Fetal and maternal hemodynamic and metabolic effects of maternal nitroglycerin infusions in sheep.  Amer. J. Obstet. Gynecol.. 176 1997;  644-650.
    Google Scholar
  • 07 Boulanger,  H., , Berkane,  N. , Pruna A. . Role of nitric oxic in pregnancy and preeclampsia.  Nephrologie. 18 1997;  81-90.
    Google Scholar
  • 08 Chuprin,  J.  R., , Rapport R.  M. . Nitroglycerin-induced desensitization of vascular smooth muscle may be mediated through cyclic GMP-disinhibition of phosphatidylinositol hydrolysis.  Experientia. 43 1986;  316-318.
    Google Scholar
  • 09 Clark,  B.  A., , Ludmir,  J. , Epstein,  F.  H. , Alvarez,  J. , Tavara,  L. , Bazul,  J. , Franco,  A. , Maradiegue,  E. , Ludmir A. . Urinary cyclic GMP, endothelin and prostaglandin E2 in normal pregnancy and preeclampsia.  Amer. J. Perinatol.. 14 1997;  559-562.
    Google Scholar
  • 10 David,  M., , Sehouli,  J. , Plischek,  S. , Halle,  H. , Lichtenegger W. . Nitroglyzerin zur intraoperativen Uterusrelaxation bei Sectio caesarea.  Z. Geburtsh. Neonatol.. 202 1998;  168-171.
    PubMedGoogle Scholar
  • 11 Davis,  W.  B., , Wells,  S.  R. , Kuller,  J.  A. , Thorp J.  M. . Analysis of the risk associated with calcium channel blockade: implications for the obstetrican-gynecologist.  Obstet. Gynecol. Surv.. 52 1997;  198-201.
    CrossrefPubMedGoogle Scholar
  • 12 De Belder,  A.  J., , Lees,  C. , Martin,  J. , Moncada,  S. , Campbell S. . Treatment of HELLP syndrome with nitric oxide donor.  Lancet. 343 1995;  124-125.
    PubMedGoogle Scholar
  • 13 Di Iorio,  R., , Marinoni,  E. , Emiliani,  S. , Villaccio,  B. , Cosmi E.  V. . Nitric oxide in preeclampsia: lack of evidence for decreased production.  Europ. J. Obstet. Gynecol. Reprod. Biol.. 76 1998;  65-70.
    PubMedGoogle Scholar
  • 14 Gazzolo,  D., , Visser,  G.  H. , Russo,  A. , Scopesi,  F. , Santi,  F. , Bruschetini P.  L. . Pregnancy-induced hypertension, antihypertensive drugs and the development of fetal behavioural states.  Early Hum. Dev.. 50 1998;  149-157.
    CrossrefPubMedGoogle Scholar
  • 15 Gonzales,  C., , Cruz,  M.  A. , Gallardo,  V. , Miguel,  P. , Carrasco G. . Relative potency of nitrovasodilatators on human placental vessels from normal and preeclamptic pregnancies.  Gynecol. Obstet. Invest.. 43 1997;  219-224.
    PubMedGoogle Scholar
  • 16 Grunewald,  C., , Kublickas,  M. , Carlstrom,  K. , Lunell,  N.  O. , Nisell H. . Obstet. Gynecol.. 86 1995;  600-604.
    PubMed
  • 17 Jennings,  R.  W., , MacGillivrav,  T.  E. , Harrison M.  R. . Nitric oxide inhibits preterm labor in the rhesus monkey.  J. Matern. Fetal. Med.. 2 1993;  170-175.
    PubMedGoogle Scholar
  • 18 Khedun,  S.  M., , Moodley,  J. , Naicker,  T. , Maharaj B. . Drug management of hypertensive disorders of pregnancy.  Pharmacol. Ther.. 74 1997;  221-258.
    PubMedGoogle Scholar
  • 19 Lechner,  W., , Bergant,  A. , Sölder,  E. , Kölle D. . Hemmung spontaner Uteruskontraktion durch Nitroglycerin.  Zbl. Gynäkol.. 116 1994;  236-238.
    PubMedGoogle Scholar
  • 20 Lees,  C., , Campbell,  S. , Jauniaux,  E. , Brown R. , et al.. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor.  Lancet. 343 1994;  1325-1326.
    CrossrefPubMedGoogle Scholar
  • 21 Lip,  A.  Y. H. , Beevers,  M. , Churchill,  D. , Shaffer,  L.  M. , Beevers D.  G. . Effect of atenolol on birth weight.  Amer. J. Cardiol.. 79 1997;  1436-1438.
    CrossrefPubMedGoogle Scholar
  • 22 Lips,  U.. Die medikamentöse Therapie der Eklampsie.  Fortschr. Med.. 102 1984;  701-704.
    PubMedGoogle Scholar
  • 23 Lonmire,  S., , Leduc,  L. , Jones,  M.  M. , Hawkins J.  L. . The hemodynamic effects of intubation during nitroglycerin infusion in severe preeclampsia.  Amer. J. Obstet. Gynecol.. 164 1991;  551-556.
    PubMedGoogle Scholar
  • 24 Montan,  S., , Anandakumar,  C. , Arulkumaran,  S. , Ingenarrson,  I. , Ratnam S.  S. . Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy induced hypertension.  Amer. J. Obstet. Gynecol.. 168 1993;  152-156.
    PubMedGoogle Scholar
  • 25 Murrell,  W.. Nitroglycerine as a remedy for angina pectoris.  Lancet. I 1879;  80-81.
    PubMedGoogle Scholar
  • 26 Natuzzi,  E.  S., , Ursell,  P.  C. , Harrison,  M. , Buscher,  C. , Riemer R.  K. . Nitric oxide synthase activity in the pregnant uterus decreases at parturition.  Biochem. Biophys. Res. Commun.. 194 1993;  18.
    PubMedGoogle Scholar
  • 27 Parker,  J.  O. , Parker J.  D. . Neurohormonal activation during nitrate therapy: a possible mechanism for tolerance.  Amer. J. Cardiol.. 70 1992;  93-97 B.
    CrossrefPubMedGoogle Scholar
  • 28 Pascoal,  I.  F., , Lindheimer,  M.  D. , Nalbantian-Brandt,  C. , Umans J.  G. . Preeclampsia selectively impairs endothelium-depent relaxation and leads to oscillatory activity in small omental arteries.  J. Clin. Invest.. 101 1998;  464-470.
    PubMedGoogle Scholar
  • 29 Poranan,  A.  K., , Aubry,  J. , Kujari,  H. , Ekblad U. . Expression of nitric oxide synthase in normal and preeclamptic placental tissue and effects of glyceryl trinitrate and shear stress on placental blood flow.  Acta Obstet. Gynecol. Scand.. 77 1998;  594-597.
    CrossrefPubMedGoogle Scholar
  • 30 Peng,  A.  T. C., , Gorman,  R. , Shulman,  S. , Demarchis E. . Intravenous nitroglycerine for uterine relaxation in the postpartum patient with retained placenta.  Anesthesiology. 71 1989;  172-173.
    PubMedGoogle Scholar
  • 31 Ramsay,  B., , de Belder,  A. , Campbell,  S. , Moncada,  S. , Martin J.  F. . A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia.  Europ. J. Clin. Invest.. 24 1994;  76-78.
    PubMedGoogle Scholar
  • 32 Rath,  W.. Aktuelle Aussagen zum Schwangerschaftshochdruck/Gestose.  Frauenarzt. 39 1998;  1220.
    PubMedGoogle Scholar
  • 33 Rey,  E., , LeLorier,  J. , Burgess,  E. , Lange,  I.  R. , Leduc L. . Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment hypertensive disorders in pregnancy.  CMAJ. 157 1997;  1245-1254.
    PubMedGoogle Scholar
  • 34 Scott,  W.  J., , Resnick,  E. , Hummler,  H. , Clozel,  J.  P. , Burgin H. . Cardiovascular alterations in rat fetuses exposed to calcium channel blockers.  Reprod. Toxicol.. 11 1997;  207-214.
    CrossrefPubMedGoogle Scholar
  • 35 Sheikh,  A.  U., , Harper M.  A. . Myocardial infarction during pregnancy: Management and outcome of two pregnancies.  Amer. J. Obstet. Gynecol.. 169 1993;  279-284.
    PubMedGoogle Scholar
  • 36 Silver,  R.  K., , Kupferminc,  M.  J. , Russell,  T.  L. , Adler,  L. , Mullen,  T.  A. , Caplan M.  S. . Evaluation of nitric oxide as a mediator of severe preeclampsia.  Amer. J. Obstet. Gynecol.. 175 1996;  1013-1017.
    PubMedGoogle Scholar
  • 37 Sladek,  S.  M., , Regenstein,  A.  C. , Lykins  D. , Roberts J.  M. . Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy.  Amer. J. Obstet. Gynecol.. 169 1993;  1285-1291.
    PubMedGoogle Scholar
  • 38 Vinatier,  D., , Dufour,  P. , Berard J. . Utilization of intravenous nitroglycerin for obstetrical emergencies.  Int. J. Gynaecol. Obstet.. 55/2 1996;  129-134.
    PubMedGoogle Scholar
  • 39 Wheeler,  M.  D., , James,  F.  M. , Meis,  P.  J. , Rose,  J.  C. , et al.. Effects of Nitroglycerine and Nitroprusside on Uterine Vasculature of Gravid Ewes.  Anesthesiology. 52 1980;  390-394.
    PubMedGoogle Scholar
  • 40 Yallampalli,  C., , Garfield,  R.  E. , Byam-Smith M. . Nitric oxide inhibits uterine constractility during pregnancy but not during delivery.  Endocrinology. 133/4 1993;  1899-1902.
    PubMedGoogle Scholar
  • 41 Zozulia,  O.  V., , Rogov,  V.  A. , Piatakova,  N.  V. , Tareeva I.  E. . Nitric oxide: is role in the development of pregnancy complications and in their prevention in women with hypertension and chronic glomerulonephritis.  Ter. Arkh.. 69 1997;  17-20.
    PubMedGoogle Scholar

Dr. Manfred Hofmann

Universitätsfrauenklinik

Langenbeckstraße

55131 Mainz